Concepts (343)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollutants | 23 | 2024 | 100 | 6.190 |
Why?
|
| Air Pollution | 18 | 2024 | 66 | 4.730 |
Why?
|
| Environmental Exposure | 21 | 2024 | 215 | 3.880 |
Why?
|
| Particulate Matter | 18 | 2024 | 70 | 3.780 |
Why?
|
| Maternal Exposure | 21 | 2022 | 147 | 3.760 |
Why?
|
| Occupational Exposure | 27 | 2022 | 128 | 3.650 |
Why?
|
| Environmental Monitoring | 25 | 2022 | 63 | 3.470 |
Why?
|
| Metals, Heavy | 3 | 2021 | 18 | 2.030 |
Why?
|
| Texas | 36 | 2023 | 3521 | 1.990 |
Why?
|
| Stillbirth | 3 | 2019 | 80 | 1.900 |
Why?
|
| Cyclonic Storms | 4 | 2021 | 76 | 1.760 |
Why?
|
| Industry | 10 | 2021 | 28 | 1.730 |
Why?
|
| Metals | 4 | 2023 | 58 | 1.730 |
Why?
|
| Residence Characteristics | 6 | 2020 | 265 | 1.550 |
Why?
|
| Community-Based Participatory Research | 2 | 2023 | 50 | 1.540 |
Why?
|
| Arsenic | 4 | 2023 | 46 | 1.540 |
Why?
|
| Disasters | 3 | 2021 | 99 | 1.480 |
Why?
|
| Mexican Americans | 6 | 2018 | 197 | 1.380 |
Why?
|
| Environmental Pollutants | 6 | 2018 | 67 | 1.370 |
Why?
|
| Premature Birth | 5 | 2018 | 380 | 1.370 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2024 | 225 | 1.350 |
Why?
|
| Ozone | 3 | 2019 | 18 | 1.280 |
Why?
|
| Stress, Psychological | 6 | 2021 | 556 | 1.220 |
Why?
|
| Oil and Gas Industry | 2 | 2018 | 5 | 1.200 |
Why?
|
| Pregnancy | 31 | 2024 | 7071 | 1.150 |
Why?
|
| Environmental Health | 3 | 2023 | 10 | 1.090 |
Why?
|
| Recycling | 2 | 2020 | 5 | 0.890 |
Why?
|
| Nitrogen Dioxide | 6 | 2022 | 16 | 0.880 |
Why?
|
| Soil Pollutants | 1 | 2021 | 9 | 0.800 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 7 | 2022 | 65 | 0.790 |
Why?
|
| Volatile Organic Compounds | 2 | 2020 | 9 | 0.780 |
Why?
|
| Adult | 45 | 2023 | 28623 | 0.750 |
Why?
|
| Deer | 1 | 2021 | 19 | 0.750 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 141 | 0.740 |
Why?
|
| Population Dynamics | 2 | 2019 | 29 | 0.730 |
Why?
|
| Disaster Planning | 1 | 2021 | 65 | 0.720 |
Why?
|
| Pregnancy Outcome | 3 | 2019 | 592 | 0.720 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2020 | 20 | 0.700 |
Why?
|
| Fires | 1 | 2020 | 13 | 0.690 |
Why?
|
| Benzene | 7 | 2020 | 24 | 0.680 |
Why?
|
| Humans | 96 | 2024 | 121743 | 0.670 |
Why?
|
| Abruptio Placentae | 1 | 2019 | 16 | 0.670 |
Why?
|
| Pregnant Women | 1 | 2020 | 149 | 0.640 |
Why?
|
| Young Adult | 23 | 2023 | 8712 | 0.630 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 103 | 0.630 |
Why?
|
| Temperature | 1 | 2019 | 304 | 0.630 |
Why?
|
| Natural Gas | 1 | 2018 | 5 | 0.620 |
Why?
|
| Female | 64 | 2024 | 64492 | 0.610 |
Why?
|
| Logistic Models | 14 | 2019 | 1756 | 0.590 |
Why?
|
| Urban Population | 6 | 2019 | 216 | 0.560 |
Why?
|
| Trace Elements | 1 | 2017 | 24 | 0.560 |
Why?
|
| Butadienes | 1 | 2016 | 19 | 0.540 |
Why?
|
| Social Class | 2 | 2017 | 180 | 0.540 |
Why?
|
| Hazardous Substances | 5 | 2015 | 17 | 0.540 |
Why?
|
| Colorectal Neoplasms | 4 | 2014 | 558 | 0.510 |
Why?
|
| Leukemia | 1 | 2019 | 377 | 0.510 |
Why?
|
| Community Participation | 1 | 2015 | 43 | 0.500 |
Why?
|
| Multilingualism | 1 | 2015 | 43 | 0.500 |
Why?
|
| Inhalation Exposure | 5 | 2020 | 34 | 0.490 |
Why?
|
| Surveys and Questionnaires | 9 | 2021 | 3619 | 0.490 |
Why?
|
| Air Pollutants, Occupational | 7 | 2006 | 18 | 0.480 |
Why?
|
| Hypertension | 3 | 2018 | 1264 | 0.470 |
Why?
|
| Case-Control Studies | 12 | 2019 | 3221 | 0.460 |
Why?
|
| Models, Theoretical | 7 | 2015 | 351 | 0.460 |
Why?
|
| Occupational Diseases | 6 | 2016 | 74 | 0.460 |
Why?
|
| Pilot Projects | 5 | 2020 | 1357 | 0.450 |
Why?
|
| Risk Assessment | 7 | 2021 | 3222 | 0.420 |
Why?
|
| Birth Certificates | 3 | 2019 | 14 | 0.410 |
Why?
|
| Cohort Studies | 12 | 2022 | 4635 | 0.400 |
Why?
|
| Endocrine Disruptors | 2 | 2022 | 50 | 0.390 |
Why?
|
| Legionellosis | 1 | 2011 | 4 | 0.380 |
Why?
|
| Water Supply | 2 | 2004 | 25 | 0.380 |
Why?
|
| Linear Models | 7 | 2017 | 655 | 0.380 |
Why?
|
| Socioeconomic Factors | 6 | 2020 | 857 | 0.370 |
Why?
|
| Mercury | 2 | 2001 | 27 | 0.370 |
Why?
|
| Water Pollutants, Chemical | 2 | 2004 | 25 | 0.370 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 802 | 0.370 |
Why?
|
| Asthma | 7 | 2014 | 742 | 0.360 |
Why?
|
| Nickel | 2 | 2001 | 22 | 0.360 |
Why?
|
| Cities | 2 | 2020 | 47 | 0.350 |
Why?
|
| Infant, Newborn | 14 | 2022 | 8088 | 0.350 |
Why?
|
| Particle Size | 4 | 2022 | 115 | 0.340 |
Why?
|
| Polybrominated Biphenyls | 2 | 2007 | 4 | 0.340 |
Why?
|
| Gestational Age | 5 | 2022 | 1112 | 0.330 |
Why?
|
| Odds Ratio | 10 | 2016 | 1226 | 0.330 |
Why?
|
| Disease Outbreaks | 1 | 2011 | 318 | 0.320 |
Why?
|
| Respiratory Tract Diseases | 3 | 2020 | 77 | 0.320 |
Why?
|
| Risk Factors | 17 | 2019 | 9677 | 0.320 |
Why?
|
| Pesticides | 3 | 2022 | 19 | 0.320 |
Why?
|
| Disinfection | 2 | 2011 | 25 | 0.320 |
Why?
|
| Agriculture | 2 | 2006 | 28 | 0.320 |
Why?
|
| Models, Statistical | 6 | 2017 | 445 | 0.320 |
Why?
|
| Cognition Disorders | 1 | 2013 | 551 | 0.320 |
Why?
|
| Bayes Theorem | 6 | 2024 | 263 | 0.310 |
Why?
|
| Male | 38 | 2023 | 59138 | 0.300 |
Why?
|
| United States | 24 | 2019 | 10415 | 0.290 |
Why?
|
| Mining | 4 | 2010 | 8 | 0.290 |
Why?
|
| Metallurgy | 4 | 2000 | 6 | 0.280 |
Why?
|
| Pregnancy Trimesters | 2 | 2018 | 33 | 0.280 |
Why?
|
| Aerosols | 3 | 2022 | 66 | 0.270 |
Why?
|
| Biomarkers | 6 | 2017 | 2922 | 0.270 |
Why?
|
| Carcinogens, Environmental | 2 | 2015 | 16 | 0.260 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2016 | 50 | 0.260 |
Why?
|
| Prevalence | 11 | 2018 | 2370 | 0.260 |
Why?
|
| Styrene | 4 | 2001 | 4 | 0.240 |
Why?
|
| Chemical Industry | 4 | 2001 | 7 | 0.240 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 1679 | 0.240 |
Why?
|
| Cleft Lip | 2 | 2017 | 127 | 0.240 |
Why?
|
| Cleft Palate | 2 | 2017 | 140 | 0.240 |
Why?
|
| SEER Program | 3 | 2014 | 192 | 0.230 |
Why?
|
| Trihalomethanes | 1 | 2004 | 2 | 0.230 |
Why?
|
| Risk | 3 | 2019 | 743 | 0.230 |
Why?
|
| United States Environmental Protection Agency | 3 | 2019 | 7 | 0.220 |
Why?
|
| Databases, Factual | 3 | 2004 | 1138 | 0.220 |
Why?
|
| Data Collection | 4 | 2023 | 383 | 0.210 |
Why?
|
| Middle Aged | 20 | 2021 | 25388 | 0.210 |
Why?
|
| Cobalt | 1 | 2022 | 17 | 0.200 |
Why?
|
| Tungsten | 1 | 2022 | 6 | 0.200 |
Why?
|
| Health Surveys | 3 | 2020 | 235 | 0.200 |
Why?
|
| Child | 10 | 2024 | 24035 | 0.200 |
Why?
|
| Soil | 1 | 2021 | 44 | 0.190 |
Why?
|
| Glyoxylates | 1 | 2001 | 4 | 0.190 |
Why?
|
| Mandelic Acids | 1 | 2001 | 6 | 0.190 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 114 | 0.190 |
Why?
|
| Toluene | 3 | 2010 | 10 | 0.190 |
Why?
|
| Xylenes | 3 | 2010 | 13 | 0.190 |
Why?
|
| Benzene Derivatives | 3 | 2010 | 19 | 0.190 |
Why?
|
| China | 1 | 2021 | 227 | 0.190 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 215 | 0.190 |
Why?
|
| Floods | 1 | 2021 | 14 | 0.190 |
Why?
|
| Exercise | 2 | 2017 | 787 | 0.180 |
Why?
|
| Respiratory Protective Devices | 1 | 2020 | 9 | 0.180 |
Why?
|
| Women, Working | 2 | 2017 | 9 | 0.180 |
Why?
|
| Birth Weight | 4 | 2022 | 333 | 0.180 |
Why?
|
| Aged | 14 | 2021 | 18464 | 0.180 |
Why?
|
| Reproducibility of Results | 5 | 2007 | 2792 | 0.180 |
Why?
|
| Spinal Dysraphism | 3 | 2015 | 262 | 0.180 |
Why?
|
| Food Contamination | 3 | 2007 | 23 | 0.170 |
Why?
|
| Feasibility Studies | 4 | 2017 | 726 | 0.170 |
Why?
|
| Cadmium | 1 | 2020 | 29 | 0.170 |
Why?
|
| Soot | 1 | 2020 | 15 | 0.170 |
Why?
|
| Vehicle Emissions | 2 | 2022 | 19 | 0.170 |
Why?
|
| Styrenes | 3 | 1996 | 6 | 0.170 |
Why?
|
| Weather | 1 | 2019 | 10 | 0.170 |
Why?
|
| Regression Analysis | 5 | 2014 | 755 | 0.170 |
Why?
|
| Registries | 3 | 2019 | 1351 | 0.170 |
Why?
|
| Urban Health | 1 | 2019 | 71 | 0.170 |
Why?
|
| Universities | 1 | 2020 | 125 | 0.170 |
Why?
|
| Child, Preschool | 8 | 2024 | 13771 | 0.170 |
Why?
|
| Adolescent | 13 | 2021 | 18879 | 0.170 |
Why?
|
| RNA, Viral | 1 | 2021 | 541 | 0.160 |
Why?
|
| Oil and Gas Fields | 1 | 2019 | 9 | 0.160 |
Why?
|
| Sister Chromatid Exchange | 2 | 1996 | 18 | 0.160 |
Why?
|
| Hypersensitivity | 1 | 2021 | 178 | 0.160 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 302 | 0.150 |
Why?
|
| Drinking Behavior | 1 | 1998 | 8 | 0.150 |
Why?
|
| Analysis of Variance | 5 | 2001 | 1004 | 0.150 |
Why?
|
| Contraceptives, Oral | 1 | 2017 | 39 | 0.150 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 2007 | 0.150 |
Why?
|
| Geography, Medical | 1 | 2017 | 16 | 0.150 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 1515 | 0.140 |
Why?
|
| Occupations | 1 | 2017 | 21 | 0.140 |
Why?
|
| Fluorocarbons | 1 | 2017 | 57 | 0.140 |
Why?
|
| Workplace | 2 | 2015 | 69 | 0.140 |
Why?
|
| Epoxy Compounds | 1 | 1996 | 18 | 0.140 |
Why?
|
| Fetal Development | 3 | 2022 | 110 | 0.140 |
Why?
|
| Molecular Weight | 1 | 2017 | 393 | 0.140 |
Why?
|
| DNA Adducts | 1 | 1996 | 76 | 0.140 |
Why?
|
| Serum Albumin | 1 | 1996 | 114 | 0.140 |
Why?
|
| Neural Tube Defects | 2 | 2010 | 351 | 0.140 |
Why?
|
| Phthalic Acids | 1 | 2016 | 7 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2020 | 15601 | 0.130 |
Why?
|
| Reproductive History | 1 | 1995 | 10 | 0.130 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1121 | 0.130 |
Why?
|
| Lead | 1 | 1995 | 23 | 0.130 |
Why?
|
| Aged, 80 and over | 7 | 2014 | 6098 | 0.120 |
Why?
|
| International Agencies | 1 | 2015 | 28 | 0.120 |
Why?
|
| Papillomaviridae | 1 | 2016 | 135 | 0.120 |
Why?
|
| Menopause | 1 | 1995 | 73 | 0.120 |
Why?
|
| Cause of Death | 2 | 2014 | 448 | 0.120 |
Why?
|
| Publications | 1 | 2015 | 31 | 0.120 |
Why?
|
| Cross-Sectional Studies | 7 | 2016 | 3286 | 0.120 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 69 | 0.120 |
Why?
|
| Chlamydia trachomatis | 1 | 2014 | 21 | 0.120 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 952 | 0.120 |
Why?
|
| Focus Groups | 1 | 2015 | 200 | 0.120 |
Why?
|
| Chlamydia Infections | 1 | 2014 | 45 | 0.120 |
Why?
|
| Prisoners | 1 | 2014 | 33 | 0.120 |
Why?
|
| Juvenile Delinquency | 1 | 2014 | 22 | 0.120 |
Why?
|
| Azithromycin | 1 | 2014 | 45 | 0.120 |
Why?
|
| Occupational Health | 3 | 2010 | 44 | 0.120 |
Why?
|
| Motor Activity | 2 | 2015 | 507 | 0.120 |
Why?
|
| Vitamin D | 1 | 2016 | 157 | 0.120 |
Why?
|
| Environment Design | 1 | 2014 | 13 | 0.120 |
Why?
|
| Iron | 1 | 2017 | 263 | 0.120 |
Why?
|
| Nutrition Surveys | 5 | 2016 | 278 | 0.120 |
Why?
|
| North America | 3 | 2000 | 233 | 0.120 |
Why?
|
| Doxycycline | 1 | 2014 | 117 | 0.110 |
Why?
|
| Europe | 3 | 2000 | 366 | 0.110 |
Why?
|
| Smoking | 3 | 1996 | 1027 | 0.110 |
Why?
|
| Erectile Dysfunction | 1 | 2016 | 168 | 0.110 |
Why?
|
| Uncertainty | 1 | 2014 | 98 | 0.110 |
Why?
|
| Population Surveillance | 3 | 2012 | 380 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 1379 | 0.110 |
Why?
|
| Poverty | 2 | 2015 | 410 | 0.110 |
Why?
|
| Craniosynostoses | 1 | 2015 | 131 | 0.110 |
Why?
|
| Insurance Claim Reporting | 1 | 2012 | 8 | 0.110 |
Why?
|
| Infant | 7 | 2024 | 12289 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 1995 | 336 | 0.100 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2003 | 7 | 0.100 |
Why?
|
| Diphosphonates | 1 | 2012 | 37 | 0.100 |
Why?
|
| Cardiovascular Diseases | 3 | 2014 | 1810 | 0.100 |
Why?
|
| Papillomavirus Infections | 1 | 2016 | 271 | 0.100 |
Why?
|
| Iron, Dietary | 1 | 2012 | 16 | 0.100 |
Why?
|
| Health Personnel | 2 | 2006 | 500 | 0.100 |
Why?
|
| Maintenance | 1 | 2011 | 1 | 0.100 |
Why?
|
| Epidemiologic Studies | 2 | 2002 | 40 | 0.100 |
Why?
|
| Gastroschisis | 1 | 2012 | 53 | 0.100 |
Why?
|
| Animals | 4 | 2021 | 33670 | 0.090 |
Why?
|
| Zinc | 1 | 2012 | 128 | 0.090 |
Why?
|
| Equipment Contamination | 1 | 2011 | 38 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 502 | 0.090 |
Why?
|
| Age Factors | 4 | 2015 | 2769 | 0.090 |
Why?
|
| Demography | 3 | 2007 | 238 | 0.090 |
Why?
|
| Time Factors | 5 | 2001 | 5995 | 0.090 |
Why?
|
| Anencephaly | 1 | 2010 | 11 | 0.090 |
Why?
|
| Research Design | 2 | 2007 | 643 | 0.080 |
Why?
|
| Gasoline | 2 | 2022 | 3 | 0.080 |
Why?
|
| Parity | 2 | 2007 | 79 | 0.080 |
Why?
|
| Creatinine | 2 | 2001 | 376 | 0.080 |
Why?
|
| Infant, Premature | 1 | 2014 | 799 | 0.080 |
Why?
|
| Prospective Studies | 5 | 2022 | 5906 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 4987 | 0.080 |
Why?
|
| Longitudinal Studies | 3 | 2003 | 1275 | 0.080 |
Why?
|
| Manufactured Materials | 2 | 1998 | 2 | 0.080 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 322 | 0.080 |
Why?
|
| Incidence | 4 | 2023 | 2992 | 0.080 |
Why?
|
| Cognition | 2 | 2024 | 732 | 0.080 |
Why?
|
| Japan | 2 | 1998 | 132 | 0.080 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 424 | 0.070 |
Why?
|
| Dementia | 1 | 2013 | 441 | 0.070 |
Why?
|
| Neoplasms | 2 | 2020 | 2748 | 0.070 |
Why?
|
| Michigan | 1 | 2007 | 39 | 0.070 |
Why?
|
| South Carolina | 1 | 2006 | 10 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2022 | 901 | 0.070 |
Why?
|
| Diet | 2 | 2011 | 1099 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 418 | 0.060 |
Why?
|
| Chlorine | 1 | 2004 | 14 | 0.060 |
Why?
|
| Inflammation | 1 | 2011 | 1393 | 0.060 |
Why?
|
| Disinfectants | 1 | 2004 | 25 | 0.060 |
Why?
|
| Water Purification | 1 | 2004 | 13 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2011 | 818 | 0.060 |
Why?
|
| Fishes | 1 | 2003 | 41 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2378 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 2 | 2015 | 202 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 1615 | 0.050 |
Why?
|
| Fetal Weight | 1 | 2022 | 52 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2010 | 275 | 0.050 |
Why?
|
| Alloys | 1 | 2022 | 15 | 0.050 |
Why?
|
| Antimony | 1 | 2022 | 11 | 0.050 |
Why?
|
| Solvents | 1 | 2022 | 42 | 0.050 |
Why?
|
| Seasons | 1 | 2004 | 297 | 0.050 |
Why?
|
| Maximum Allowable Concentration | 1 | 2001 | 7 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2023 | 301 | 0.050 |
Why?
|
| Transients and Migrants | 1 | 2001 | 24 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2001 | 21 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2001 | 74 | 0.050 |
Why?
|
| Italy | 1 | 2001 | 110 | 0.050 |
Why?
|
| Sociological Factors | 1 | 2021 | 8 | 0.050 |
Why?
|
| Laboratories | 1 | 2022 | 83 | 0.050 |
Why?
|
| Medicaid | 2 | 2014 | 238 | 0.050 |
Why?
|
| Community-Institutional Relations | 1 | 2020 | 30 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 1801 | 0.050 |
Why?
|
| Western Australia | 1 | 2000 | 4 | 0.040 |
Why?
|
| Body Mass Index | 3 | 2010 | 1457 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 479 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2001 | 386 | 0.040 |
Why?
|
| Sex Factors | 2 | 2015 | 1226 | 0.040 |
Why?
|
| Databases, Bibliographic | 1 | 1998 | 20 | 0.040 |
Why?
|
| Norway | 1 | 2017 | 20 | 0.040 |
Why?
|
| Baths | 1 | 1998 | 16 | 0.040 |
Why?
|
| Menstruation | 1 | 2017 | 27 | 0.040 |
Why?
|
| Carcinogenicity Tests | 1 | 1996 | 20 | 0.040 |
Why?
|
| Biotransformation | 1 | 1996 | 48 | 0.040 |
Why?
|
| Employment | 1 | 2017 | 67 | 0.030 |
Why?
|
| Dogs | 1 | 1998 | 775 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 1996 | 86 | 0.030 |
Why?
|
| Time | 1 | 1996 | 91 | 0.030 |
Why?
|
| Bias | 1 | 1996 | 113 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2016 | 228 | 0.030 |
Why?
|
| Cervix Uteri | 1 | 2016 | 70 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 176 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 60 | 0.030 |
Why?
|
| Workload | 1 | 2016 | 145 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1995 | 24 | 0.030 |
Why?
|
| Posture | 1 | 2015 | 153 | 0.030 |
Why?
|
| Postmenopause | 1 | 1995 | 123 | 0.030 |
Why?
|
| Income | 1 | 1995 | 133 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2014 | 39 | 0.030 |
Why?
|
| Food-Processing Industry | 1 | 1993 | 1 | 0.030 |
Why?
|
| Decision Making | 1 | 2018 | 651 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 1199 | 0.030 |
Why?
|
| Public Health | 1 | 2015 | 252 | 0.030 |
Why?
|
| Health Behavior | 1 | 2015 | 378 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2015 | 605 | 0.030 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 51 | 0.030 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 226 | 0.020 |
Why?
|
| Meat | 1 | 2012 | 48 | 0.020 |
Why?
|
| Vitamin E | 1 | 2012 | 64 | 0.020 |
Why?
|
| Health Status | 1 | 2014 | 369 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 329 | 0.020 |
Why?
|
| Heme | 1 | 2012 | 52 | 0.020 |
Why?
|
| Micronutrients | 1 | 2012 | 67 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 437 | 0.020 |
Why?
|
| DNA | 1 | 1996 | 1607 | 0.020 |
Why?
|
| Job Description | 1 | 2010 | 9 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2014 | 1460 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2011 | 86 | 0.020 |
Why?
|
| Epidemiological Monitoring | 1 | 2011 | 59 | 0.020 |
Why?
|
| Construction Materials | 1 | 2010 | 4 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1284 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2010 | 1395 | 0.020 |
Why?
|
| Eating | 1 | 2012 | 355 | 0.020 |
Why?
|
| Life Style | 2 | 2003 | 391 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 813 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2015 | 507 | 0.020 |
Why?
|
| Pain | 1 | 2012 | 450 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1473 | 0.020 |
Why?
|
| Mass Screening | 1 | 2014 | 776 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2014 | 11685 | 0.020 |
Why?
|
| Folic Acid | 1 | 2010 | 290 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 1983 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 756 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2010 | 457 | 0.020 |
Why?
|
| Great Lakes Region | 1 | 2003 | 1 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2001 | 178 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4207 | 0.010 |
Why?
|
| United States Occupational Safety and Health Administration | 1 | 1997 | 3 | 0.010 |
Why?
|
| Ventilation | 1 | 1993 | 5 | 0.010 |
Why?
|
| Netherlands | 1 | 1993 | 35 | 0.010 |
Why?
|
| United Kingdom | 1 | 1993 | 189 | 0.010 |
Why?
|
| Models, Biological | 1 | 1993 | 1434 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1990 | 416 | 0.000 |
Why?
|